Medicare Enrolled

Dr. Toby Yaltho, MD

Neurology · Sugar Land, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
16605 SOUTHWEST FWY, Sugar Land, TX 77479
2814946387
In practice since 2007 (18 years)
NPI: 1033399837 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Yaltho from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Yaltho? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Yaltho

Dr. Toby Yaltho is a neurology in Sugar Land, TX, with 18 years in practice. Based on federal Medicare data, Dr. Yaltho performed 17,244 Medicare services across 803 unique beneficiaries.

Between the years covered by Open Payments, Dr. Yaltho received a total of $234,977 from 84 pharmaceutical and/or device companies across 1321 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Yaltho is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice▲ Top 5% volume in TX$ $234,977 industry payments

Medicare Practice Summary

Medicare Utilization ↗
17,244
Medicare services
Top 5% in TX for neurology
803
Unique beneficiaries
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~958 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Botox injection, per unit15,000$5$12
Injection, rimabotulinumtoxinb, 100 units1,100$10$20
Office visit, established patient (30-39 min)497$84$236
Office visit, established patient, complex (40-54 min)300$121$316
Office visit, established patient (20-29 min)62$67$159
New patient office visit, complex (60-74 min)60$142$450
Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box35$126$397
Injection of chemical for paralysis of salivary glands on both sides of mouth32$87$229
Needle measurement of electrical activity in arm or leg muscles, complete study29$74$281
Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, first 15 minutes with qualified health professional29$37$118
Injection of chemical for paralysis of nerve muscles on side of face28$104$503
Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator22$13$144
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or21$19$97
Hospital follow-up visit, moderate complexity17$61$158
New patient office visit (45-59 min)12$120$363
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$234,977
Total received (2018-2024)
Avg $33,568/year across 7 years
Top 3% in TX for neurology
84
Companies
1,321
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$218,040 (92.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,050 (6.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$887 (0.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$26,059
2023
$40,272
2022
$41,225
2021
$49,096
2020
$43,286
2019
$17,738
2018
$17,300

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$53,749
AbbVie Inc.
$48,766
Allergan, Inc.
$41,490
Allergan Inc.
$18,254
MDD US Operations, LLC
$17,810
US WorldMeds, LLC
$14,088
Acorda Therapeutics, Inc
$13,891
Sunovion Pharmaceuticals Inc.
$10,389
Teva Pharmaceuticals USA, Inc.
$1,340
ACADIA Pharmaceuticals Inc
$1,323
Amneal Pharmaceuticals LLC
$1,261
Boston Scientific Corporation
$915
Amgen Inc.
$887
SK Life Science, Inc.
$872
UCB, Inc.
$853
Abbott Laboratories
$783
Novartis Pharmaceuticals Corporation
$780
Neurocrine Biosciences, Inc.
$542
PFIZER INC.
$533
Genentech USA, Inc.
$498
Biogen, Inc.
$401
Lilly USA, LLC
$359
EMD Serono, Inc.
$337
GENZYME CORPORATION
$262
Harmony Biosciences LLC
$261
Medtronic, Inc.
$249
Bausch Health US, LLC
$231
Grifols USA, LLC
$222
Lundbeck LLC
$207
Medtronic USA, Inc.
$200
ARGENX US, INC.
$193
Eisai Inc.
$184
Adamas Pharmaceuticals, Inc.
$173
Takeda Pharmaceuticals U.S.A., Inc.
$161
Biohaven Pharmaceuticals, Inc.
$157
Biohaven Pharmaceutical Holding Company Ltd.
$144
Corium, LLC
$139
Merz Pharmaceuticals, LLC
$127
Merz North America, Inc.
$122
Horizon Therapeutics plc
$116
Kyowa Kirin, Inc.
$110
Supernus Pharmaceuticals, Inc.
$108
Alexion Pharmaceuticals, Inc.
$104
MITSUBISHI TANABE PHARMA AMERICA, INC.
$86
ARBOR PHARMACEUTICALS, INC.
$77
Neurelis, Inc.
$70
Upsher-Smith Laboratories LLC
$69
JAZZ PHARMACEUTICALS INC.
$68
GE HEALTHCARE
$61
Almatica Pharma LLC
$59
Vanda Pharmaceuticals Inc.
$49
Egalet US Inc
$48
W. L. Gore & Associates, Inc.
$46
HARMONY BIOSCIENCES LLC
$44
Ipsen Biopharmaceuticals, Inc
$40
LivaNova USA, Inc.
$39
IMPEL PHARMACEUTICALS INC.
$38
ASSERTIO THERAPEUTICS, Inc.
$36
Aucta Pharmaceuticals, Inc.
$33
BOSTON SCIENTIFIC CORPORATION
$32
PIRAMAL CRITICAL CARE
$32
Greenwich Biosciences, Inc.
$29
Averitas Pharma Inc.
$28
Avion Pharmaceuticals
$27
CATALYST PHARMACEUTICALS, INC.
$26
GE Healthcare
$26
TG Therapeutics, Inc.
$25
AstraZeneca Pharmaceuticals LP
$24
Mallinckrodt LLC
$24
Avadel CNS Pharmaceuticals, LLC
$23
EISAI INC.
$22
Vertical Pharmaceuticals, LLC
$20
MERZ NORTH AMERICA, INC.
$19
Strongbridge US INC.
$18
DePuy Synthes Sales Inc.
$18
Nuvectra Corporation
$16
Arbor Pharmaceuticals, Inc.
$16
Azurity Pharmaceuticals, Inc.
$16
AQUESTIVE THERAPEUTICS, INC.
$16
Fujirebio Diagnostics, Incorporated
$15
Zyla Life Sciences, Inc.
$15
Impax Laboratories, Inc.
$13
AbbVie, Inc.
$13
InSightec,Inc
$12
Top 3 companies account for 61.3% of total payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA · ACTIVA PC · ADLARITY · ADUHELM · AGAMREE · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aimovig · Algovita · Austedo XR · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Briviact · CARDIOFORM Septal Occluder · COMIRNATY · COPAXONE · CREXONT · Cambia · Cenobamate · DUOPA · DYSPORT · Dayvigo · Dhivy · Duopa · Dysport · EMGALITY · EPIDIOLEX · EVUSHELD · Edarbyclor · Epidiolex · Exablate · Fintepla · GABLOFEN · GAMMAGARD · GENERAL DBS · GENERAL DBS · GILENYA · GOCOVRI · GRALISE · Gamunex-C · General - DBS · HETLIOZ · HORIZANT · HYQVIA · Horizant · INBRIJA · INFINITY · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KEVEYIS · KYNMOBI · LUMRYZ · Leqembi · MAVENCLAD · MIGRANAL · MYOBLOC · Motpoly XR · NAMZARIC · NOURIANZ · NUPLAZID · NURTEC ODT · Nourianz · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · OSMOLEX ER · Ocrevus · Ongentys · PLEGRIDY · QULIPTA · QUTENZA · RADICAVA · REXULTI · REYVOW · RYTARY · Rystiggo · SKYCLARYS · SOLIRIS · SPRIX · SYMPAZAN · SYMPHONY · TECFIDERA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VERCISE · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VRAYLAR · VYALEV · VYEPTI · VYVGART · VYVGART HYTRULO · Vercise · Vimpat · WAKIX · Wakix · XCOPRI · XEOMIN · XYWAV · Xadago · Xeomin
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (93%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for neurology in TX.

Equivalent to $1,363 per 100 Medicare services performed
Looking for a neurology in Sugar Land?
Compare neurologys in the Sugar Land area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Geographic Context

Neurologys within 10 mi
332
Per 100K population
38.6
County median income
$113,409
Nearest hospital
HOUSTON METHODIST SUGARLAND HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Yaltho is a mixed practice specialist, with above-average Medicare volume (top 5% in TX), and high industry engagement (speaking/promotional, top 3%), with 18 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Yaltho experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Yaltho performed 15,000 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Yaltho receive payments from pharmaceutical companies?
Yes. Dr. Yaltho received a total of $234,977 from 84 companies across 1,321 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Yaltho's costs compare to other neurologys in Sugar Land?
Dr. Yaltho's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Yaltho) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →